Medium-chain triglycerides increase muscle mass and grip strength in human trials, with independent labs reporting both changes. Human cognitive outcomes range from improvement to no clear effect; a mouse study shows no clear lifespan effect at tested concentrations. Some papers declare company ties, and some authors work for companies including Nisshin OilliO Group and Meiji.
44 findings in 18 papers from 2012 to 2026, 2 of them since July 2026
Independent labs found the same change in people. 9 independent labs in 4 countries; 2 trials, none about aging, 1 with no results posted.
“As a result of the 12-week intervention, physical function (PF), general health (GH), vitality (VT) and mental component summary (MCS) showed significant increases in scores in all MCT supplement groups compared to the control group, either in actual or change scores.”
Humans: replicated by independent labs. Worms or flies and mice: a single group. Cells: nothing yet.
C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.
Labs are independent when their papers share no last author and no institution.
Against: findings that point the other way from most findings on the same outcome.
About aging: the drug’s trials about aging. The total counts its trials for every use.
No results posted: trials that ended over a year ago with no results on ClinicalTrials.gov and no paper reporting them.
Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.
9 independent labs in 4 countries
1 finding against
2 trials, none about aging, 1 with no results posted
Funders: Tohoku University Center for Gender Equality Promotion and others
Medium-chain triglycerides improve cognitive function in humans (frail elderly nursing home residents) (+3.5 points MMSE; difference vs LCT group significant (P < 0.05)).
“MCT supplementation increased the Mini-Mental State Examination (MMSE) score by 3.5 points at the 3-mo intervention from baseline (P < 0.001)”
Human trialfrail elderly nursing home residents6 g/d3 monthsn = 64
Medium-chain triglycerides improve cognitive function in humans.
“proven to benefit both individuals with normal cognition and those suffering from mild cognitive impairment, Alzheimer's disease, and other cognitive disorders.”
ReviewNormal cognition, mild cognitive impairment, Alzheimer's disease, or other cognitive disorders
Medium-chain triglycerides improve grip strength in humans.
“Although no intergroup differences were observed in grip strength, the left-hand maximum grip strength significantly increased from baseline in the high-dose octanoic acid group and the decanoic acid group that consumed 6 g of MCT per day.”
Medium-chain triglycerides decrease glycolysis in humans (post-intervention).
“For post-intervention glucose metabolism, MCT decreased the SUV mean in the lower skeletal muscles (psoas and vastus medialis), with a slight elevation in the liver, but no significant changes in blood glucose levels.”
Human trialpost-interventionpsoas and vastus medialis3 consecutive monthsn = 68
Medium-chain triglycerides improve physical function in humans (frail elderly nursing home residents) (+39 ± 42 s (breakfast) and +20 ± 32 s (dinner)).
“right knee extension time by 39 ± 42 s (P<0.01) and 20 ± 32 s (P<0.05)”
Human trialfrail elderly nursing home residents6 g/day1.5 monthsn = 37
Medium-chain triglycerides increase muscle mass in humans (frail elderly nursing home residents) (+1.1 ± 0.8 cm2 (breakfast) and +1.6 ± 2.5 cm2 (dinner)).
“MCT supplementation in breakfast and dinner groups respectively increased right arm muscle area from baseline by 1.1 ± 0.8 cm2 (P<0.001) and 1.6 ± 2.5 cm2 (P<0.001)”
Human trialfrail elderly nursing home residents6 g/day1.5 monthsn = 37
Medium-chain triglycerides increase knee extension strength in humans.
“At week 12 of the intervention, all MCT supplement groups showed an increase from baseline in right knee extension strength, compared to the control group.”
Medium-chain triglycerides improve knee extension strength in humans.
“In terms of the change from pre-intake values, the right or bilateral knee extension strength of all MCT intake groups was higher than that of the control group.”
Medium-chain triglycerides increase muscle density in humans (post-intervention).
“In addition, MCT increased the post-intervention HU of these two muscles, and a significant difference was detected in the psoas muscle compared to the placebo control.”
Human trialpost-interventionpsoas and vastus medialis3 consecutive monthsn = 68
Medium-chain triglycerides protect against sarcopenia.
“For muscle health, MCTs help optimize energy metabolism and protein homeostasis, showing promise for countering sarcopenia and improving exercise performance.”
Medium-chain triglycerides increase body mass index in humans (undernourished or at risk of malnutrition) (from 18.8 ± 2.2 to 19.7 ± 2.3 kg/m2 (p=0.002)).
“In the intervention group, BMI increased from 18.8 ± 2.2 kg/m2 at baseline to 19.7 ± 2.3 kg/m2 after 5 months”
Human trialundernourished or at risk of malnutritionsnack containing MCTs (135-136 kcal, 0.4 g protein)10 g/day5 months
Medium-chain triglycerides increase body weight in humans (MCTs 1.2 kg vs. LCTs 0.2 kg).
“In the fully adjusted model (model 3), statistically significant increases from baseline in the changes after the 3.0-month intervention in measurements in the MCTs-containing group, relative to the LCTs-containing group, were manifested in body weight (adjusted mean change from baseline: MCTs 1.2 kg vs. LCTs 0.2 kg, p = 0.023”
Studies link medium-chain triglycerides with cognitive function.
Cognitive function
↔no changein humans1
1 study
Medium-chain triglycerides are associated with cognitive function in humans (frail elderly nursing home residents) (+1.5 ± 3.0 points (breakfast) and +1.0 ± 2.1 points (dinner), P=0.06).
“Mini-Mental State Examination score by 1.5 ± 3.0 points (P=0.06) and 1.0 ± 2.1 points (P=0.06)”
Human trialfrail elderly nursing home residents6 g/day1.5 monthsn = 37
Restoring lipid balance through medium-chain triglycerides or fatty acid inhibition protected worms from alpha-synuclein-driven movement deficits.Restoring lipid balance through medium-chain triglycerides or fatty acid inhibition protected worms from alpha-synuclein-driven movement deficits.